Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses

  • Siân E. Jossi
  • , Melissa Arcuri
  • , Areej Alshayea
  • , Ruby R. Persaud
  • , Edith Marcial-Juárez
  • , Elena Palmieri
  • , Roberta Di Benedetto
  • , Marisol Pérez-Toledo
  • , Jamie Pillaye
  • , Will M. Channell
  • , Anna E. Schager
  • , Rachel E. Lamerton
  • , Charlotte N. Cook
  • , Margaret Goodall
  • , Takeshi Haneda
  • , Andreas J. Bäumler
  • , Lucy H. Jackson-Jones
  • , Kai-Michael Toellner
  • , Calman A. MacLennan
  • , Ian R. Henderson
  • Francesca Micoli, Adam F. Cunningham

    Research output: Contribution to journalArticlepeer-review

    Original languageUndefined/Unknown
    JournalFrontiers in Immunology
    DOIs
    Publication statusPublished (VoR) - 23 Mar 2023

    Cite this